Therefore, our results suggest that E1B-55 kD-deleted adenovirus may have therapeutic potential, especially in combination with replication-defective adenoviral vector expressing K1–5, for the treatment of patients with bladder cancer. Here, KRT15 is linked to urinary bladder cancer.